Valvular aortic stenosis in the elderly

Cardiology in Review

Volumn 15, Issue 5, 2007, Pages 217-225

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Angina; Anticoagulant therapy; Aortic stenosis; Aspirin; Cardiovascular surgery; Coronary artery disease; Doppler echocardiography; Heart failure; Heart murmurs; Mechanical prosthetic valve; Porcine bioprosthesis; Syncope

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; NITROPRUSSIDE SODIUM; PLACEBO; ROSUVASTATIN; SIMVASTATIN; WARFARIN;

ANGINA PECTORIS; AORTA STENOSIS; AORTA VALVE; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BIOPROSTHESIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ENDOCARDITIS; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VALVE STENOSIS; HISTORY; HUMAN; HYPERCOAGULABILITY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL EXAMINATION; PREVALENCE; REVIEW; SYNCOPE; SYSTOLIC HEART MURMUR; THORAX RADIOGRAPHY; THROMBOEMBOLISM; TRANSLUMINAL VALVULOPLASTY;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANTIBIOTIC PROPHYLAXIS; AORTIC VALVE STENOSIS; BALLOON DILATATION; COMORBIDITY; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; FIBRINOLYTIC AGENTS; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; PREVALENCE;

EID: 34548015482     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e31805f6796     Document Type: Review

References (99)

1. Roberts WC, Perloff JK, Costantino T. Severe valvular aortic stenosis in patients over 65 years of age. Am J Cardiol. 1971;27:497-506.
2. Waller BF, Roberts WC. Cardiovascular disease in the very elderly. An analysis of 40 necropsy patients aged 90 years or over. Am J Cardiol. 1983;51:403-421.
3. Aronow WS, Schwartz KS, Koenigsberg M. Correlation of aortic cuspal and aortic root disease with aortic systolic ejection murmurs and with mitral anular calcium in persons older than 62 years in a long-term health care facility. Am J Cardiol. 1986;58:651-652.
4. Aronow WS, Kronzon I. Prevalence and severity of valvular aortic stenosis determined by Doppler echocardiography and its association with echocardiographic and electrocardiographic left ventricular hypertrophy and physical signs of aortic stenosis in elderly patients. Am J Cardiol. 1991;67:776-777.
5. Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220-1225.
6. Aronow WS, Ahn C, Kronzon I. Association of mitral annular calcium and of aortic cuspal calcium with coronary artery disease in older patients. Am J Cardiol. 1999;84:1084-1085.
7. Aronow WS, Ahn C, Shirani J, et al. Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol. 1999;83:599-600.
8. Roberts WC, Perloff JK. Mitral valvular disease. A clinicopathologic survey of the conditions causing the mitral valve to function normally. Ann Intern Med. 1972;77:939-975.
9. Nair CK, Aronow WS, Stokke K, et al. Cardiac conduction defects in patients older than 60 years with aortic stenosis with and without mitral anular calcium. Am J Cardiol. 1984;53:169-172.
10. Sell S, Scully RE. Aging changes in the aortic and mitral valves. Am J Pathol. 1965;46:345-365.
11. Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Circulation. 1994;90:844-853.
12. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol. 1997;29:630-634.
13. Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol. 1987;59:998-999.
14. Lindroos M, Kupari M, Valvanne J, et al. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J. 1994;15:865-870.
15. Aronow WS, Kronzon I, Schoenfeld MR. Prevalence of extracranial carotid arterial disease and of valvular aortic stenosis and their association in the elderly. Am J Cardiol. 1995;75:304-305.
16. Adler Y, Levinger U, Koren A, et al. Relation of nonobstructive aortic valve calcium to carotid arterial atherosclerosis. Am J Cardiol. 2000;86:1102-1105.
17. Aronow WS, Ahn C, Kronzon I. Association of valvular aortic stenosis with symptomatic peripheral arterial disease in older persons. Am J Cardiol. 2001;88:1046-1047.
18. Nassimiha D, Aronow WS, Ahn C, et al. Rate of progression of valvular aortic stenosis in persons ≥60 years. Am J Cardiol. 2001;87:807-809.
19. Nassimiha D, Aronow WS, Ahn C, et al. Association of coronary risk factors with progression of valvular aortic stenosis in older persons. Am J Cardiol. 2001;87:1313-1314.
20. Palta S, Pai AM, Gill KS, et al. New insights into the progression of aortic stenosis. Implications for secondary prevention. Circulation. 2000;101:3497-2502.
21. Roberts WC. The senile cardiac calcification syndrome. Am J Cardiol. 1986;58:572-574.
22. Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium and phosphorus, diabetes mellitus, aortic valve stenosis and history of systemic hypertension with presence or absence of mitral anular calcium in persons older than 62 years in a long-term health care facility. Am J Cardiol. 1987;59:381-382.
23. Aronow WS, Ahn C, Kronzon I, et al. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol. 2001;88:693-695.
24. Novaro GM, Tiong IY, Pearce GL, et al. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation. 2001;104:2205-2209.
25. Bellamy MF, Pellikka PA, Klarich KW, et al. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol. 2002;40:1723-1730.
26. Pai RG, Kapoor N, Bansal RC, et al. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg. 2006;82:2116-2122.
27. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol. 2007;49:554-561.
28. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Eng J Med. 2005;352:2389-2397.
29. Grundy SM, Cleeman JI, Merz CNB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-239.
30. Griffin BP. Statins in aortic stenosis. New data from a prospective clinical trial. J Am Coll Cardiol. 2007;49:562-564.
31. Aronow WS, Ahn C, Kronzon I. Comparison of echocardiographic abnormalities in African-American, Hispanic, and white men and women aged >60 years. Am J Cardiol. 2001;87:1131-1133.
32. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases. A population-based study. Lancet. 2006;368:1005-1011.
33. Kennedy JW, Twiss RD, Blackmon JR, et al. Quantitative angiocardiography. III. Relationships of left ventricular pressure, volume and mass in aortic valve disease. Circulation. 1968;38:838-845.
34. Hood WP Jr, Rackley CE, Rolett EL. Wall stress in the normal and hypertrophied human left ventricle. Am J Cardiol. 1968;22:550-558.
35. Carroll JD, Carroll EP, Feldman T, et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation. 1992;86:1099-1107.
36. Villari B, Vassalli G, Schneider J, et al. Age dependency of left ventricular diastolic function in pressure overload hypertrophy. J Am Coll Cardiol. 1997;29:181-186.
37. Rajappan K, Rimoldi OE, Dutka DP, et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation. 2002;105:470-476.
38. Stott DK, Marpole DG, Bristow JD, et al. The role of left atrial transport in aortic and mitral stenosis. Circulation. 1970;41:1031-1041.
39. Vekshtein VI, Alexander RW, Yeung AC, et al. Coronary atherosclerosis is associated with left ventricular dysfunction and dilatation in aortic stenosis. Circulation. 1990;82:2068-2074.
40. Aronow WS, Ahn C, Kronzon I, et al. Prognosis of congestive heart failure in patients aged ≥62 years with unoperated severe valvular aortic stenosis. Am J Cardiol. 1993;72:846-848.
41. Hess OM, Villari B, Krayenbuehl HP. Diastolic dysfunction in aortic stenosis. Circulation. 1993;87(5 Suppl):IV73-IV76.
42. Julius BK, Spillmann M, Vassalli G, et al. Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. Circulation. 1997;95:892-898.
43. Rapp AH, Hillis LD, Lange RA, et al. Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris. Am J Cardiol. 2001;87:1215-1217.
44. Aronow WS, Ahn C, Shirani J, et al. Comparison of frequency of new coronary events in older persons with mild, moderate, and severe valvular aortic stenosis with those without aortic stenosis. Am J Cardiol. 1998;81:647-649.
45. Ross J Jr, Braunwald E. Aortic stenosis. Circulation. 1968;38(1 Suppl):61-67.
46. Frank S, Johnson A, Ross J Jr. Natural history of valvular aortic stenosis. Br Heart J. 1973;35:41-56.
47. Braunwald E. On the natural history of severe aortic stenosis. J Am Coll Cardiol. 1990;15:1018-1020.
48. Bruns DL, Van Der Hauwaert LG. The aortic systolic murmur developing with increased age. Br Heart J. 1958;20:370-378.
49. Aronow WS, Kronzon I. Correlation of prevalence and severity of valvular aortic stenosis determined by continuous-wave Doppler echocardiography with physical signs of aortic stenosis in patients aged 62 to 100 years with aortic systolic ejection murmurs. Am J Cardiol. 1987;60:399-401.
50. Folland ED, Kriegel BJ, Henderson WG, et al. Implications of third heart sounds in patients with valvular heart disease. N Engl J Med. 1992;327:458-462.
51. Finegan RE, Gianelly RE, Harrison DC. Aortic stenosis in the elderly. Relevance of age to diagnosis and treatment. N Engl J Med. 1969;281:1261-1264.
52. Aronow WS, Epstein S, Koenigsberg M, et al. Usefulness of echocardiographic abnormal left ventricular ejection fraction, paroxysmal ventricular tachycardia and complex ventricular arrhythmias in predicting new coronary events in patients over 62 years of age. Am J Cardiol. 1988;61:1349-1351.
53. Rispler S, Rinkevich D, Markiewicz W, et al. Missed diagnosis of severe symptomatic aortic stenosis. Am J Cardiol. 1995;76:728-730.
54. Teirstein P, Yeager M, Yock PG, et al. Doppler echocardiographic measurements of aortic valve area in aortic stenosis: a noninvasive application of the Gorlin formula. J Am Coll Cardiol. 1986;8:1059-1065.
55. Come PC, Riley MF, McKay RG, et al. Echocardiographic assessment of aortic valve area in elderly patients with aortic stenosis and of changes of valve area after percutaneous balloon valvuloplasty. J Am Coll Cardiol. 1987;10:115-124.
56. Shah PM, Graham BM. Management of aortic stenosis: is cardiac catheterization necessary? Am J Cardiol. 1991;67:1031-1032.
57. Slater J, Gindea AJ, Freedberg RS, et al. Comparison of cardiac catheterization and Doppler echocardiography in the decision to operate in aortic and mitral valve disease. J Am Coll Cardiol. 1991;17:1026-1036.
58. Nassimiha D, Aronow WS, Ahn C, et al. Comparison of aortic valve area determined by Doppler echocardiography and cardiac catheterization in 75 older patients with valvular aortic stenosis. Cardiovasc Rev Rep. 2000;21:507-509.
59. Galan A, Zoghbi WA, Quinones MA. Determination of severity of valvular aortic stenosis by Doppler echocardiography and relation of findings to clinical outcome and agreement with hemodynamic measurements determined at cardiac catheterization. Am J Cardiol. 1991;67:1007-1012.
60. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 practice guidelines for the management of patients with valvular heart disease: Executive Summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). Developed in collaboration with the Society of Cardiovascular Anesthesiologists. Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:598-675.
61. Rapaport E. Natural history of aortic and mitral valve disease. Am J Cardiol. 1975;35:221-227.
62. Malouf JF, Enriquez-Sarano M, Pellikka PA, et al. Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. J Am Coll Cardiol. 2002;40:789-795.
63. Livanainen AM, Lindroos M, Tilvis R, et al. Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol. 1996;78:97-101.
64. Otto CM, Lind BK, Kitzman DW, et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142-147.
65. Faggiano P, Antonini-Canterin F, Erlicher A, et al. Progression of aortic valve sclerosis to aortic stenosis. Am J Cardiol. 2003;91:99-101.
66. Kennedy KD, Nishimura RA, Holmes DR Jr, et al. Natural history of moderate aortic stenosis. J Am Coll Cardiol. 1991;17:313-319.
67. Hammermeister KE, Cantor AB, Burchfield CM, et al. Clinical haemodynamic and angiographic predictors of survival in unoperated patients with aortic stenosis. The VA Cooperative Study on Valvular Heart Disease. Eur Heart J. 1988;9(Suppl E):65-69.
68. Turina J, Hess O, Sepulcri F, et al. Spontaneous course of aortic valve disease. Eur Heart J. 1987;8:471-483.
69. Kelly TA, Rothbart RM, Cooper CM, et al. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol. 1988;61:123-130.
70. Pellikka PA, Nishimura RA, Bailey KR, et al. The natural history of adults with asymptomatic hemodynamically significant aortic stenosis. J Am Coll Cardiol. 1990;15:1012-1017.
71. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000;343:611-617.
72. Smith RL, Larsen D, Crawford MH, et al. Echocardiographic predictors of survival in low gradient aortic stenosis. Am J Cardiol. 2000;86:804-807.
73. Monin J-L, Monchi M, Gest V, et al. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients. Risk stratification by low-dose dobutamine echocardiography. J Am Coll Cardiol. 2001;37:2101-2107.
74. Monin J-L, Quere J-P, Monchi M, et al. Low-gradient aortic stenosis. Operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003;108:319-324.
75. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation. 1997;96:358-366.
76. Tresch DD, Knickelbine T. Aortic valvular stenosis in the elderly: a disorder with a favorable outcome if correctly diagnosed and treated. Cardiovasc Rev Rep. 1994;15:35-38.
77. Khot UN, Novaro GM, Popovic ZB, et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Eng J Med. 2003;348:1756-1763.
78. Hammermeister K, Sethi GK, Henderson WG, et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs Randomized Trial. J Am Coll Cardiol. 2000;36:1152-1158.
79. Borkon AM, Soule LM, Baughman KL, et al. Aortic valve selection in the elderly patient. Ann Thorac Surg. 1988;46:270-277.
80. Culliford AT, Galloway AC, Colvin SB, et al. Aortic valve replacement for aortic stenosis in persons aged 80 years and older. Am J Cardiol. 1991;67:1256-1260.
81. Gherli T, Colli A, Fragnito C, et al. Comparing warfarin with aspirin after biological aortic valve replacement. Circulation. 2004;110:496-500.
82. Arom K, Nicoloff D, Lindsay W, et al. Aortic valve replacement in the elderly: operative risks and long-term results [abstract]. J Am Coll Cardiol. 1990;15:96A.
83. Asimakopoulos G, Edwards M-B, Taylor KM. Aortic valve replacement in patients 80 years of age and older. Survival and cause of death based on 1100 cases: collective results from the UK Heart Valve Registry. Circulation. 1997;96:3403-3408.
84. Pereira JJ, Lauer MS, Bashir M, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1356-1363.
85. Unic D, Leacche M, Paul S, et al. Early and late results of isolated and combined heart valve surgery in patients ≥80 years of age. Am J Cardiol. 2005;95:1500-1503.
86. Levy F, Garayalde E, Quere JP, et al. Prognostic value of preoperative atrial fibrillation in patients with aortic stenosis and low ejection fraction having aortic valve replacement. Am J Cardiol. 2006;98:809-811.
87. Gilchrist IC, Waxman HL, Kurnik PB. Improvement in early diastolic filling dynamics after aortic valve replacement. Am J Cardiol. 1990;66:1124-1129.
88. Villari B, Vassalli G, Monrad ES, et al. Normalization of diastolic dysfunction in aortic stenosis late after valve replacement. Circulation. 1995;91:2353-2358.
89. Kuhl HP, Franke A, Puschmann D, et al. Regression of left ventricular mass one year after aortic valve replacement for pure severe aortic stenosis. Am J Cardiol. 2002;89:408-413.
90. Gjertsson P, Caidahl K, Bech-Hanssen O. Left ventricular diastolic dysfunction late after aortic valve replacement in patients with aortic stenosis. Am J Cardiol. 2005;96:722-727.
91. Hoffman A, Burckhardt D. Patients at risk for cardiac death late after aortic valve replacement. Am Heart J. 1990;120:1142-1147.
92. Connolly HM, Oh JK, Orszulak TA, et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators. Circulation. 1997;95:2395-2400.
93. O'Keefe JH Jr, Vlietstra RE, Bailey KR, et al. Natural history of candidates for balloon aortic valvuloplasty. Mayo Clin Proc. 1987;62:986-991.
94. Kuntz RE, Tosteson ANA, Berman AD, et al. Predictors of event-free survival after balloon aortic valvuloplasty. N Engl J Med. 1991;325:17-23.
95. Cheitlin MD. Severe aortic stenosis in the sick octogenarian. A clear indicator for balloon valvuloplasty as the initial procedure. Circulation. 1989;80:1906-1908.
96. Rahimtoola SH. Catheter balloon valvuloplasty for severe calcific aortic stenosis: a limited role. J Am Coll Cardiol. 1994;23:1076-1078.
97. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43:698-703.
98. Feldman T, Herrmann HC, Goar FS. Percutaneous treatment of valvular heart disease: catheter-based aortic valve replacement and mitral valve repair therapies. Am J Geriatr Cardiol. 2006;15:291-301.
99. Brinster DR, Byrne M, Rogers CD, et al. Effectiveness of same day percutaneous coronary intervention followed by minimally invasive aortic valve replacement for aortic stenosis and moderate coronary disease ("hybrid approach"). Am J Cardiol. 2006;98:1501-1503.